Physician profile
Lisa Block
NPI 1942645288
$1,545.01
in general payments reported to CMS, 2019-2025
9 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $231 · 2021: $66.66 · 2022: $362 · 2023: $143 · 2024: $244 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $372.29 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $294.23 | 2019-2024 | |
| Integra Lifesciences Corporation | $233.15 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $202.51 | 2020-2024 | Na |
| Kls-Martin L.P. | $133.43 | 2020 | |
| Motiva USA, LLC | $129.63 | 2025 | |
| Innovation Technologies INC | $119.50 | 2022 | |
| Tela Bio, INC. | $41.66 | 2024 | Ovitex 2s |
| Stryker Corporation | $18.61 | 2024 | Na, Universal Neuro 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.